Search - tctmd.com

Displaying 881 - 900 of 1179

Sort: Relevancy | Date

News Daily News

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Jason Kahn

January 22, 2013

News Daily News

Endovascular Therapy for DVT Appears Safe, Effective in Registries

January 22, 2013

Presentation

Should Duration of Dual Antiplatelet Therapy Depend on the Type and/or Potency of Implanted Stent?

Presenter: Marco Valgimigli

January 16, 2013

News Daily News

Unknowns Predominate in Variable Clopidogrel Response

January 16, 2013

News Daily News

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Yael L. Maxwell

January 13, 2013

News Daily News

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Caitlin E. Cox

January 09, 2013

News Daily News

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

January 07, 2013

News Daily News

MUSTELA Published: Thrombectomy Shows Mixed Results in STEMI

December 26, 2012

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

Yael L. Maxwell

December 19, 2012

News Daily News

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Caitlin E. Cox

December 19, 2012

Presentation

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Presenter: J. Yu

December 17, 2012

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

News Daily News

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

Caitlin E. Cox

December 16, 2012

News Daily News

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Caitlin E. Cox

December 16, 2012

News Daily News

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Yael L. Maxwell

December 13, 2012

News Daily News

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

Jason Kahn

December 13, 2012

News Daily News

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Yael L. Maxwell

December 13, 2012

Presentation

Benefit of Long-term Dual Antiplatelet Therapy (DAPT) in Patients Treated with DES

Presenter: Suresh R. Mulukutla

December 05, 2012

Advertisement

Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type

Endovascular Therapy for DVT Appears Safe, Effective in Registries

Should Duration of Dual Antiplatelet Therapy Depend on the Type and/or Potency of Implanted Stent?

Unknowns Predominate in Variable Clopidogrel Response

Prasugrel Reloading Feasible After Clopidogrel Pretreatment in ACS Patients

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

PLATO Substudy: Ticagrelor Advantage Persists After First Ischemic Event

MUSTELA Published: Thrombectomy Shows Mixed Results in STEMI

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

Clopidogrel Pretreatment Reduces Cardiac Events, Not Mortality, After PCI

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Risk Factor Control Linked to Better Outcomes After Peripheral Intervention

El Control del Factor de Riesgo se asocia a Mejores Resultados tras una Intervención Periférica

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Italian Generic Clopidogrel Worse Than Brand Name at Suppressing Platelets

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Benefit of Long-term Dual Antiplatelet Therapy (DAPT) in Patients Treated with DES

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content